Response | All patients |
---|---|
n = 30 | |
No. of pts. (%) | |
irBOR | |
irCR | 1 (3) |
irPR | 7 (23) |
irSD | 9 (30) |
irPD | 13 (43) |
irDCR | 17 (57) |
irCBR | 13 (43) |
irBORR | 8 (27) |
ir immune related, BOR best overall response, CR complete response, PR partial response, SD stable disease, PD progressive disease, BORR best overall response rate, DCR disease control rate (CR + PR + SD), CBR clinical benefit rate (CR + PR + SD ≥ 24 weeks)